Tengjun Biotechnology Corp. Deferred Revenue
Tengjun Biotechnology Corp. had Deferred Revenue of $4.28 million as of 2022-03-31, per its 10-Q filed 2022-05-13.
Discontinued › Balance Sheet › Liabilities
us-gaap:DeferredRevenue · last filed 2022-05-13
- 2022-03-31: Deferred Revenue $4.28M.
| Period end | Deferred Revenue |
|---|---|
| 2022-03-31 | $4.28M 10-Q · filed 2022-05-13 |